Skip to content

Karyopharm Therapeutics Inc.: filings

Every Karyopharm Therapeutics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 52 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026441270001193125-26-347906
10-Q2026-05-14fiscal Q1 202644930001193125-26-222827
10-K2026-02-13fiscal FY 2025491300001193125-26-049397
10-Q2025-11-03fiscal Q3 2025441270001193125-25-261667
10-Q2025-08-11fiscal Q2 2025451290000950170-25-106238
10-Q2025-05-12fiscal Q1 202543910000950170-25-069231
10-K2025-02-19fiscal FY 2024491300000950170-25-022765
10-Q2024-11-05fiscal Q3 2024441270000950170-24-121076
10-Q2024-08-06fiscal Q2 2024451290000950170-24-091210
10-Q2024-05-08fiscal Q1 202442890000950170-24-055672
10-K2024-02-29fiscal FY 2023491300000950170-24-022650
10-Q2023-11-02fiscal Q3 2023441270000950170-23-057754
10-Q2023-08-02fiscal Q2 2023441270000950170-23-036780
10-Q2023-05-04fiscal Q1 202343910000950170-23-017483
10-K2023-02-17fiscal FY 2022481280000950170-23-003129
10-Q2022-11-03fiscal Q3 2022421230000950170-22-021917
10-Q2022-08-04fiscal Q2 2022421230000950170-22-014788
10-Q2022-05-05fiscal Q1 202237790000950170-22-007564
10-K2022-03-01fiscal FY 2021441130000950170-22-002548
10-Q2021-11-03fiscal Q3 2021381070000950170-21-002729
10-Q2021-08-05fiscal Q2 2021381070000950170-21-000948
10-Q2021-05-04fiscal Q1 202138810000950170-21-000073
10-K2021-02-24fiscal FY 2020431110001193125-21-054811
10-Q2020-11-02fiscal Q3 2020371050001564590-20-049664
10-Q2020-08-04fiscal Q2 2020371030001564590-20-036120
10-Q2020-05-05fiscal Q1 202037770001193125-20-133703
10-K2020-02-26fiscal FY 2019411020001193125-20-049115
10-Q2019-11-04fiscal Q3 2019381020001193125-19-282510
10-Q2019-08-07fiscal Q2 201935990001193125-19-215344
10-Q2019-05-09fiscal Q1 201935740001193125-19-142973
10-K2019-02-28fiscal FY 2018361260001193125-19-057610
10-Q2018-11-08fiscal Q3 201834920001193125-18-322696
10-Q2018-08-07fiscal Q2 201834920001193125-18-241301
10-Q2018-05-10fiscal Q1 201829590001193125-18-159200
10-K2018-03-15fiscal FY 2017291060001193125-18-084024
10-Q2017-11-02fiscal Q3 201728760001564590-17-021223
10-Q2017-08-08fiscal Q2 201728750001193125-17-251322
10-Q2017-05-04fiscal Q1 201729570001193125-17-158670
10-K2017-03-16fiscal FY 2016301060001193125-17-084396
10-Q2016-11-07fiscal Q3 201627710001193125-16-761702
10-Q2016-08-04fiscal Q2 201627710001193125-16-671775
10-Q2016-05-09fiscal Q1 201626540001193125-16-583808
10-K2016-03-15fiscal FY 2015301050001193125-16-505181
10-Q2015-11-09fiscal Q3 201527700001193125-15-370974
10-Q2015-08-10fiscal Q2 201527710001193125-15-283822
10-Q2015-05-11fiscal Q1 201528570001193125-15-181874
10-K2015-03-13fiscal FY 2014311070001193125-15-091264
10-Q2014-11-10fiscal Q3 201426680001104659-14-078971
10-Q2014-08-07fiscal Q2 201426660001104659-14-057869
10-Q2014-05-08fiscal Q1 201426600001104659-14-036479
10-K2014-03-21fiscal FY 2013271090001047469-14-002800
10-Q/A2013-12-23fiscal Q3 201324680001104659-13-091964

Inspect the source

Entity
Karyopharm Therapeutics Inc. / CIK 0001503802
Captured
2026-09-20T09:12:00.482Z
SEC response SHA-256
fc01ae30f39685ae62660019ff98663a0f1e1ff79fbb8ba679388fab92736423

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001503802.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))